Basic information Safety Supplier Related

BISINDOLYLMALEIMIDE III

Basic information Safety Supplier Related

BISINDOLYLMALEIMIDE III Basic information

Product Name:
BISINDOLYLMALEIMIDE III
Synonyms:
  • BISINDOLYLMALEIMIDE III
  • 3-[1-(3-aminopropyl)indol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione
  • 1H-Pyrrole-2,5-dione, 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1H-indol-3-yl)-
  • 3-(1-(3-Aminopropyl)-1H-indol-3-yl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione
  • Bisindolylmaleimide III, PKC inhibitor
  • Bisindolylmaleimide III, 10 mM in DMSO
CAS:
137592-43-9
MF:
C23H20N4O2
MW:
384.43
Product Categories:
  • Amines, Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals
Mol File:
Mol File
More
Less

BISINDOLYLMALEIMIDE III Chemical Properties

Boiling point:
708.7±60.0 °C(Predicted)
Density 
1.41±0.1 g/cm3(Predicted)
solubility 
DMSO: soluble; Methanol: soluble
form 
A crystalline solid
pka
8.15±0.60(Predicted)
color 
Brown to reddish brown
More
Less

BISINDOLYLMALEIMIDE III Usage And Synthesis

Description

Bisindolylmaleimide III was developed as a protein kinase C (PKC) inhibitor with structural similarity to the nonspecific PKC inhibitor staurosporine. At 1 μM, bisindolylmaleimide III inhibits 93% of PKCα kinase activity and also inhibits many other protein kinases including, S6K1, MAPKAP-K1, RSK2 and MSK1 with similar potency. Additionally, it inhibits PDK1, an important kinase in the insulin signaling pathway, with an IC50 value of 3.8 μM.

Uses

Bisindolylmaleimide III is a protein kinase C inhibitor and was also shown to exhibit inhibitory activities towards PDK1, an important kinase in the insulin signaling pathway,

Definition

ChEBI: Bisindolylmaleimide III is a member of maleimides and a member of indoles. It has a role as an EC 2.7.11.13 (protein kinase C) inhibitor. It is functionally related to a maleimide.

IC 50

PKCα

References

[1] PETER D. DAVIS. Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides[J]. Journal of Medicinal Chemistry, 1992, 35 1: 177-184. DOI: 10.1021/jm00079a024
[2] DAVID SORIANO-CASTELL  Pamela M  Antonio Currais. Defining a pharmacological inhibitor fingerprint for oxytosis/ferroptosis[J]. Free Radical Biology and Medicine, 2021, 171: Pages 219-231. DOI: 10.1016/j.freeradbiomed.2021.05.023

BISINDOLYLMALEIMIDE IIISupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Shanghai TaoSu Biochemical Technology Co., Ltd.
Tel
021-33632979
Email
info@tsbiochem.com
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
More
Less

BISINDOLYLMALEIMIDE III(137592-43-9)Related Product Information